Could a simple pill prevent long COVID? major trial seeks answers
NCT ID NCT05852873
First seen Nov 21, 2025 · Last updated May 10, 2026 · Updated 15 times
Summary
This study tests whether taking Paxlovid early during a COVID-19 infection can prevent long-COVID symptoms like fatigue, shortness of breath, and brain fog. About 2,000 adults aged 18-64 with a recent positive test and symptoms will receive either Paxlovid or a placebo. Researchers will compare how many people in each group have long-COVID symptoms three months later.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Haukeland University Hospital
Bergen, Vestland, 5021, Norway
Conditions
Explore the condition pages connected to this study.